» Articles » PMID: 19081093

Myeloperoxidase Overexpression in Children with Hypercholesterolemia

Overview
Journal Atherosclerosis
Publisher Elsevier
Date 2008 Dec 17
PMID 19081093
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Studies conducted in healthy children showed that biomarkers of oxidative stress decreased with increasing age from 1 to 11 years. No data have been reported concerning the behavior of age-related oxidative stress in hypercholesterolemic children.

Objective: Aim of this study was to test if children with hypercholesterolemia have prolonged exposure to enhanced oxidative stress and to study the underlying mechanism.

Methods: We performed a cross-sectional study comparing 8-hydroxy-2'deoxyguanosine, oxidized-LDL and myeloperoxidase plasma levels in 95 normocholesterolemic and 95 hypercholesterolemic children.

Results: Compared to normocholesterolemic children, those with hypercholesterolemia had higher 8-hydroxy-2'deoxyguanosine, oxidized-LDL and myeloperoxidase plasma levels. A correlation analysis of the overall population showed that total cholesterol was directly correlated with 8-hydroxy-2'deoxyguanosine, oxidized-LDL and myeloperoxidase. Stepwise linear regression showed that only total cholesterol, 8-hydroxy-2'deoxyguanosine and myeloperoxidase levels predicted oxidized-LDL plasma levels. In normocholesterolemic children oxidized-LDL and myeloperoxidase plasma levels significantly decreased from first (1-5 years) to second (6-9 years) quartile of age. In hypercholesterolemic children 8-hydroxy-2'deoxyguanosine, oxidized-LDL and myeloperoxidase plasma levels did not show significant differences among quartiles of age.

Conclusion: This study shows that an early and persistent oxidative stress is detected in hypercholesterolemic children and that myeloperoxidase up-regulation might play a role.

Citing Articles

Cinnamaldehyde exerts vasculoprotective effects in hypercholestrolemic rabbits.

Nour O, Shehatou G, Rahim M, El-Awady M, Suddek G Naunyn Schmiedebergs Arch Pharmacol. 2018; 391(11):1203-1219.

PMID: 30058017 DOI: 10.1007/s00210-018-1547-8.


Association between Myeloperoxidase Levels and Risk of Insulin Resistance in Egyptian Obese Women.

Zaki M, Basha W, Reyad H, Mohamed R, Hassan N, Kholousi S Open Access Maced J Med Sci. 2018; 6(4):629-633.

PMID: 29731928 PMC: 5927491. DOI: 10.3889/oamjms.2018.164.


Vascular endothelial dysfunction and pharmacological treatment.

Su J World J Cardiol. 2015; 7(11):719-41.

PMID: 26635921 PMC: 4660468. DOI: 10.4330/wjc.v7.i11.719.


Plant-based, no-added-fat or American Heart Association diets: impact on cardiovascular risk in obese children with hypercholesterolemia and their parents.

Macknin M, Kong T, Weier A, Worley S, Tang A, Alkhouri N J Pediatr. 2015; 166(4):953-9.e1-3.

PMID: 25684089 PMC: 4380801. DOI: 10.1016/j.jpeds.2014.12.058.


Myeloperoxidase is an early biomarker of inflammation and cardiovascular risk in prepubertal obese children.

Olza J, Aguilera C, Gil-Campos M, Leis R, Bueno G, Martinez-Jimenez M Diabetes Care. 2012; 35(11):2373-6.

PMID: 22912422 PMC: 3476926. DOI: 10.2337/dc12-0614.